The ATP8B1 Polyclonal Antibody (PAC045686) is a valuable tool for researchers studying ATP8B1, a protein involved in lipid transport and bile acid metabolism. This antibody was raised in rabbits and exhibits high reactivity with human samples, making it an ideal choice for Western blot applications. By binding specifically to ATP8B1, this antibody enables researchers to detect and analyze the protein in various cell types, facilitating investigations into liver diseases, lipid metabolism disorders, and bile duct dysfunction.ATP8B1, also known as a phospholipid flippase, plays a crucial role in maintaining cellular membrane integrity and regulating lipid composition.
Dysregulation of ATP8B1 function has been implicated in various liver disorders, cholestasis, and gallstone formation. By understanding the mechanisms underlying ATP8B1 activity, researchers can develop targeted therapies for treating liver conditions and metabolic disorders related to impaired lipid transport.Overall, the ATP8B1 Polyclonal Antibody (PAC045686) is a valuable asset for researchers interested in exploring the role of ATP8B1 in health and disease, providing a powerful tool for investigating lipid metabolism, bile acid transport, and liver function.
Antibody Name:
ATP8B1 Antibody (PACO45686)
Antibody SKU:
PACO45686
Size:
50ug
Host Species:
Rabbit
Tested Applications:
ELISA, IF
Recommended Dilutions:
ELISA:1:2000-1:10000, IF:1:50-1:200
Species Reactivity:
Human
Immunogen:
Recombinant Human Phospholipid-transporting ATPase IC protein (217-330AA)
Immunofluorescent analysis of HepG2 cells using PACO45686 at dilution of 1:100 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L).
Background:
Catalytic component of a P4-ATPase flippase complex which catalyzes the hydrolysis of ATP coupled to the transport of aminophospholipids from the outer to the inner leaflet of various membranes and ensures the maintenance of asymmetric distribution of phospholipids. Phospholipid translocation seems also to be implicated in vesicle formation and in uptake of lipid signaling molecules. May play a role in asymmetric distribution of phospholipids in the canicular membrane. May have a role in transport of bile acid, into the canaliculus, uptake of bile acid, from intestinal contents into intestinal mucosa or both. In cooperation with ABCB4 may be involved in establishing integrity of the canalicular membrane thus protecting hepatocytes from bile salts. Together with TMEM30A is involved in uptake of the synthetic drug alkylphospholipid perifosine. Involved in the microvillus formation in polarized epithelial cells; the function seems to be independent from its flippase activity. Required for the preservation of cochlear hair cells in the inner ear. May act as cardiolipin transporter during inflammatory injury.
Synonyms:
Phospholipid-transporting ATPase IC (EC 3.6.3.1) (ATPase class I type 8B member 1) (Familial intrahepatic cholestasis type 1) (P4-ATPase flippase complex α subunit ATP8B1), ATP8B1, ATPIC FIC1 PFIC
UniProt Protein Function:
ATP8B1: May play a role in the transport of aminophospholipids from the outer to the inner leaflet of various membranes and the maintenance of asymmetric distribution of phospholipids in the canicular membrane. May have a role in transport of bile acids into the canaliculus, uptake of bile acids from intestinal contents into intestinal mucosa or both. Defects in ATP8B1 are the cause of progressive familial intrahepatic cholestasis type 1 (PFIC1); also known as Byler disease. PFIC1 is an autosomal recessive disorder, characterized by early infancy cholestasis, that may be initially episodic but progresses to malnutrition, growth retardation and end-stage liver disease before adulthood. Defects in ATP8B1 are the cause of benign recurrent intrahepatic cholestasis type 1 (BRIC1); also known as Summerskill syndrome. BRIC is characterized by intermittent episodes of cholestasis without progression to liver failure. There is initial elevation of serum bile acids, followed by cholestatic jaundice which generally spontaneously resolves after periods of weeks to months. The cholestatic attacks vary in severity and duration. Patients are asymptomatic between episodes, both clinically and biochemically. Defects in ATP8B1 can be associated with intrahepatic cholestasis of pregnancy (ICP); also known as pregnancy-related cholestasis. ICP is a multifactorial liver disorder of pregnancy. It presents during the second or, more commonly, the third trimestre of pregnancy with intense pruritus which becomes more severe with advancing gestation and cholestasis. Cholestasis results from abnormal biliary transport from the liver into the small intestine. ICP causes fetal distress, spontaneous premature delivery and intrauterine death. ICP patients have spontaneous and progressive disappearance of cholestasis after delivery. Belongs to the cation transport ATPase (P-type) (TC 3.A.3) family. Type IV subfamily.Protein type: Membrane protein, integral; Hydrolase; Membrane protein, multi-pass; EC 3.6.3.1; Transporter, ion channel; TransporterChromosomal Location of Human Ortholog: 18q21.31Cellular Component: apical plasma membrane; endoplasmic reticulum; Golgi apparatus; plasma membraneMolecular Function: phospholipid-translocating ATPase activity; protein bindingBiological Process: Golgi organization and biogenesis; multidrug transport; negative regulation of transcription, DNA-dependent; phospholipid translocation; regulation of microvillus biogenesisDisease: Cholestasis, Benign Recurrent Intrahepatic, 1; Cholestasis, Intrahepatic, Of Pregnancy, 1; Cholestasis, Progressive Familial Intrahepatic, 1
UniProt Protein Details:
NCBI Summary:
This gene encodes a member of the P-type cation transport ATPase family, which belongs to the subfamily of aminophospholipid-transporting ATPases. The aminophospholipid translocases transport phosphatidylserine and phosphatidylethanolamine from one side of a bilayer to another. Mutations in this gene may result in progressive familial intrahepatic cholestasis type 1 and in benign recurrent intrahepatic cholestasis. [provided by RefSeq, Jul 2008]